Dominari Holdings Logo
US0088753043
A3DMBK
DOMH

Dominari Holdings

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  0
Vendi
  0

  • Dominari Holdings changes terms for Series A warrants and offers reduced exercise price

    Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » Altro su de.investing.com


  • Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity

    Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » Altro su de.investing.com


  • Dominari Holdings announces $10 million special dividend

    Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » Altro su de.investing.com

Nel 2026, Dominari Holdings ha già distribuito 1,01 € di dividendi. L'ultimo pagamento è avvenuto a maggio.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Dominari Holdings ha registrato ricavi pari a 14,71 Mln € e un utile netto di -4,36 Mln €
(EUR) giugno 2026
YoY
Ricavi 14,71 Mln 49,15%
Utile lordo 14,71 Mln 49,15%
Utile netto -4,36 Mln 130,96%
EBITDA -2,05 Mln 87,45%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
37,38 Mln €
Numero di azioni
24,24 Mln
Massimo/minimo a 52 settimane
5,48 € - 1,53 €
Rendimento da dividendo
65,36%
Dividendi TTM
1,01 €
Beta
0,88
Rapporto P/E
-0,49
Rapporto PEG
0,00
Rapporto P/B
1,80
Rapporto P/S
0,31

Profilo aziendale

Dominari Holdings Inc., una società di biotecnologie, si concentra sullo sviluppo di terapie antitumorali a piccola molecola. La pipeline di terapie della società comprende trattamenti per il cancro alla prostata, il cancro al pancreas, la leucemia mieloide acuta (AML) e la leucemia linfoblastica acuta. Sta sviluppando DHA-dFdC, un candidato farmaco per il pancreas, e KPC34, un trattamento a piccola molecola per la leucemia mieloide acuta e la leucemia linfoblastica acuta. La società sta inoltre sviluppando una piattaforma antivirale che inibisce la replicazione di virus, tra cui il virus dell'influenza, l'Ebolavirus e il virus di Marburg, SARS-CoV, MERS-CoV e SARS-CoV-2. Ha accordi di licenza con la University of Texas, la University of Maryland Baltimore, Silo Pharma Inc. e Wake Forest University Health Sciences. La società era precedentemente nota come AIkido Pharma Inc. e ha cambiato il proprio nome in Dominari Holdings Inc. nel dicembre 2022. Dominari Holdings Inc. è stata fondata nel 1967 e ha sede a New York, New York.

Nome
Dominari Holdings
CEO
Anthony C. Hayes
Sede centrale New York City, ny
Stati Uniti
Sito web
Settore
Finanza
Industria
Servizi finanziari
Quotazione in borsa
18/03/1980
Dipendenti 36

Simboli di borsa

Borsa Simbolo
NASDAQ
DOMH
Frankfurt
BP2A.F
Düsseldorf
BP2A.DU
🍪

Parqet  usa i cookie. Scopri di più